Phase 1 study of CA-4948, a novel inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK4) in patients with R/R non-Hodgkin lymphoma (NHL) Meeting Abstract
| Authors: | Younes, A.; Nowakowski, G.; Rosenthal, A.; Leslie, L.; Tun, H.; Lunning, M.; Isufi, I.; Martell, R.; Patel, K. |
| Abstract Title: | Phase 1 study of CA-4948, a novel inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK4) in patients with R/R non-Hodgkin lymphoma (NHL) |
| Meeting Title: | 7th Annual Meeting of the Society of Hematologic Oncology (SOHO 2019) |
| Keywords: | dlbcl; tlr; myd88; nhl; abcl; aggressive b-cell lymphoma; irak4 |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 19 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Sep 11-14 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2019-09-01 |
| Start Page: | S256 |
| End Page: | S257 |
| Language: | English |
| ACCESSION: | WOS:000483480700208 |
| DOI: | 10.1016/j.clml.2019.07.168 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: ABCL-350 -- Source: Wos |
